B-Cell Targeted Therapies in Patients with Multiple Sclerosis and Incidence of Headache: A Systematic Review and Meta-Analysis

B-Cell Targeted Therapies in Patients with Multiple Sclerosis and Incidence of Headache: A Systematic Review and Meta-Analysis

Background: Multiple Sclerosis treatment with B-cell targeted therapies may be associated with an increased incidence of headache. We aimed to find and compare the association of B-cell targeted therapies with the incidence of headache in patients with Multiple Sclerosis. Methods: In a systematic ba...

Full description

Bibliographic Details
Main Authors: Theodoros Mavridis, Nikolaos Papagiannakis, Marianthi Breza, Georgios D. Vavougios, Kostas Patas, Ariadne Daponte, Achilleas Laskaratos, Paraschos Archontakis-Barakakis, Ioannis Pantazopoulos, Dimos D. Mitsikostas
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Journal of Personalized Medicine
Subjects:
B-cell targeted therapies
headache incidence
cladribine
ocrelizumab
ofatumumab
ublituximab
Online Access:https://www.mdpi.com/2075-4426/12/9/1474

Internet

https://www.mdpi.com/2075-4426/12/9/1474

Similar Items